1887

Chapter 71 : Susceptibility Test Methods: Fastidious Bacteria

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Susceptibility Test Methods: Fastidious Bacteria , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap71-1.gif /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap71-2.gif

Abstract:

Most fastidious bacteria do not grow satisfactorily in standard in vitro susceptibility test systems that use unsupple-mented media. Clinical and Laboratory Standards Institute (CLSI) has also published an approved guideline for testing infrequently isolated or fastidious bacteria including spp., spp., spp., spp., spp. (not ), , spp., , the HACEK group, spp., spp., , , spp., spp., and spp. In addition to conventional MIC test methods (e.g., agar dilution or broth dilution methods), the Etest MIC determination method has been used to test many types of fastidious bacteria. The limitations of this method include its cost and lack of clearance by the U.S. Food and Drug Administration (FDA) for testing many less commonly encountered fastidious bacteria. This chapter summarizes the standard methods recommended by CLSI for antimicrobial susceptibility testing of spp. (including ), , , and . Methods for testing the infrequently isolated or fastidious bacteria included in the CLSI M45 guideline are summarized to include testing potential agents of bioterrorism. The incidence of resistance, test methods, and indications for testing and the reporting of results are provided.

Citation: Hindler J, Jorgensen J. 2011. Susceptibility Test Methods: Fastidious Bacteria , p 1180-1203. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch71

Key Concept Ranking

Lower Respiratory Tract Infections
0.43084258
Antimicrobial Susceptibility Testing
0.41124958
0.43084258
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555816728.chap71
1. Abadi, F. J.,, D. E. Yakubu,, and T. H. Pennington. 1995. Antimicrobial susceptibility of penicillin-sensitive and penicillinresistant meningococci. J. Antimicrob. Chemother. 35:687690.
2. Adam, H. J.,, D. J. Hoban,, A. S. Gin,, and G. G. Zhanel. 2009. Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006. Int. J. Antimicrob. Agents 34:8285.
3. Ahmed, R.,, T. Hassall,, B. Morland,, and J. Gray. 2003. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem. Pediatr. Hematol. Oncol. 20:439444.
4. Alcala, B.,, C. Salcedo,, L. de la Fuente,, L. Arreaza,, M. J. Uria,, R. Abad,, R. Enriquez,, J. A. Vazquez,, M. Motge,, and J. de Batlle. 2004. Neisseria meningitidis showing decreased susceptibility to ciprofloxacin: first report in Spain. J. Antimicrob. Chemother. 53:409.
5. Andrews, J. M.,, and R. Wise. 2002. Susceptibility testing of Bacillus species. J. Antimicrob. Chemother. 49:10401042.
6. Baddour, L. M.,, W. R. Wilson,, A. S. Bayer,, V. G. Fowler, Jr.,, A. F. Bolger,, M. E. Levison,, P. Ferrieri,, M. A. Gerber,, L. Y. Tani,, M. H. Gewitz,, D. C. Tong,, J. M. Steckelberg,, R. S. Baltimore,, S. T. Shulman,, J. C. Burns,, D. A. Falace,, J. W. Newburger,, T. J. Pallasch,, M. Takahashi,, and K. A. Taubert. 2005. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111:e394e434.
7. Bakeli, G.,, K. Sato,, W. Kumita,, R. Saito,, E. Ono,, T. Chida,, and N. Okamura. 2008. Antimicrobial susceptibility and mechanism of quinolone resistance in Campylobacter jejuni strains isolated from diarrheal patients in a hospital in Tokyo. J. Infect. Chemother. 14:342348.
8. Baker, C. N. 1992. The E-Test and Campylobacter jejuni. Diagn. Microbiol. Infect. Dis. 15:469472.
9. Baker, C. N.,, D. G. Hollis,, and C. Thornsberry. 1985. Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth. J. Clin. Microbiol. 22:212215.
10. Baker-Austin, C.,, J. V. McArthur,, A. H. Lindell,, M. S. Wright,, R. C. Tuckfield,, J. Gooch,, L. Warner,, J. Oliver,, and R. Stepanauskas. 2009. Multi-site analysis reveals widespread antibiotic resistance in the marine pathogen Vibrio vulnificus. Microb. Ecol. 57:151159.
11. Baykam, N.,, H. Esener,, O. Ergonul,, S. Eren,, A. K. Celikbas,, and B. Dokuzoguz. 2004. In vitro antimicrobial susceptibility of Brucella species. Int. J. Antimicrob. Agents 23:405407.
12. Beekmann, S. E.,, D. J. Diekema,, K. P. Heilmann,, S. S. Richter,, and G. V. Doern. 2006. Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study. Eur. J. Clin. Microbiol. Infect. Dis. 25:335339.
13. Beekmann, S. E.,, K. P. Heilmann,, S. S. Richter,, J. Garciade- Lomas,, and G. V. Doern. 2005. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. Int. J. Antimicrob. Agents. 25:148156.
14. Bell, J. M.,, J. D. Turnidge,, and R. N. Jones. 2009. Development of a disk diffusion method for testing Moraxella catarrhalis susceptibility using Clinical and Laboratory Standards Institute methods: a SENTRY Antimicrobial Surveillance Program report. J. Clin. Microbiol. 47:21872193.
15. Best, L. M.,, D. J. Haldane,, M. Keelan,, D. E. Taylor,, A. B. Thomson,, V. Loo,, C. A. Fallone,, P. Lyn,, F. M. Smaill,, R. Hunt,, C. Gaudreau,, J. Kennedy,, M. Alfa,, R. Pelletier,, and S. J. Veldhuyzen Van Zanten. 2003. Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and Etest methods. Antimicrob. Agents Chemother. 47:31383144.
16. Betriu, C.,, M. Gomez,, A. Sanchez,, A. Cruceyra,, J. Romero,, and J. J. Picazo. 1994. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob. Agents Chemother. 38:21832186.
17. Biedenbach, D. J.,, J. M. Bell,, H. S. Sader,, J. D. Turnidge,, and R. N. Jones. 2009. Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates. Antimicrob. Agents Chemother. 53:12601263.
18. Biedenbach, D. J.,, and R. N. Jones. 1996. Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration. J. Clin. Microbiol. 34:32143217.
19. Billal, D. S.,, M. Hotomi,, and N. Yamanaka. 2007. Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae? Antimicrob. Agents Chemother. 51:34633464.
20. Blasi, F.,, D. J. Farrell,, and L. Dubreuil. 2009. Antibacterial activity of telithromycin and comparators against pathogens isolated from patients with community-acquired respiratory tract infections: the Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin study year 5 (2003-2004). Diagn. Microbiol. Infect. Dis. 63:302308.
21. Block, C.,, Y. Davidson,, and N. Keller. 1998. Unreliability of disk diffusion test for screening for reduced penicillin susceptibility in Neisseria meningitidis. J. Clin. Microbiol. 36:31033104.
22. Botha, P. 1988. Penicillin-resistant Neisseria meningitidis in southern Africa. Lancet i:54.
23. Bouchillon, S. K.,, J. L. Johnson,, D. J. Hoban,, T. M. Stevens,, and B. M. Johnson. 2005. Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin. J. Antimicrob. Chemother. 56:224227.
24. Bouvet, A.,, A. C. Cremieux,, A. Contrepois,, J. M. Vallois,, C. Lamesch,, and C. Carbon. 1985. Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci. Antimicrob. Agents Chemother. 28:607611.
25. Bradley, J. S.,, and J. D. Connor. 1991. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr. Infect. Dis. J. 10:871873.
26. Brigante, G. R.,, F. A. Luzzaro,, B. Pini,, G. Lombardi,, G. Sokeng,, and A. Q. Toniolo. 2007. Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system. BMC Microbiol. 7:46.
27. Brown, D. F. J.,, R. Hope,, D. M. Livermore,, G. Brick,, K. Broughton,, R. C. George,, R. Reynolds, and the BSAC Working Parties on Resistance Surveillance. 2008. Nonsusceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06. J. Antimicrob. Chemother. 62:ii75ii85.
28. Brown, S. D.,, D. J. Farrell,, and I. Morrissey. 2004. Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study. J. Clin. Microbiol. 42:49804987.
29. Bruckner, L.,, and F. Gigliotti. 2006. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance. Semin. Pediatr. Infect. Dis. 17:153160.
30. Burucoa, C.,, M. Garnier,, C. Silvain,, and J. L. Fauchere. 2008. Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori. J. Clin. Microbiol. 46:23202326.
31. Buu-Hoi, A.,, C. Le Bouguenec,, and T. Horaud. 1990. Highlevel chromosomal gentamicin resistance in Streptococcus agalactiae (group B). Antimicrob. Agents Chemother. 34:985988.
32. Campos, J.,, G. Trujillo,, T. Seuba,, and A. Rodriguez. 1992. Discriminative criteria for Neisseria meningitidis isolates that are moderately susceptible to penicillin and ampicillin. Antimicrob. Agents Chemother. 36:10281031.
33. Cannon, J. P.,, T. A. Lee,, J. T. Bolanos,, and L. H. Danziger. 2005. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur. J. Clin. Microbiol. Infect. Dis. 24:3140.
34. Castanheira, M.,, A. C. Gales,, A. C. Pignatari,, R. N. Jones,, and H. S. Sader. 2006. Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Microb. Drug Resist. 12:9198.
35. Castanheira, M.,, R. N. Jones,, and D. M. Livermore. 2009. Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp. Diagn. Microbiol. Infect. Dis. 63:426433.
36. Cavallo, J.-D.,, F. Ramisse,, M. Girardet,, J. Vaissaire,, M. Mock,, and E. Hernandez. 2002. Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000. Antimicrob. Agents Chemother. 46:23072309.
37.Centers for Disease Control and Prevention. 2008. Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae United States, 2006-2007. MMWR Morb. Mortal. Wkly. Rep. 57:13531355.
38.Centers for Disease Control and Prevention. 2009. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2006. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
39.Centers for Disease Control and Prevention. 2009. Sexually Transmitted Disease Surveillance 2007 Supplement, Gonococcal Isolate Surveillance Project (GISP) Annual Report—2007. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
40.Centers for Disease Control and Prevention. 2007. Update to CDC’s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb. Mortal. Wkly. Rep. 56:332336.
41.Centers for Disease Control and Prevention. 2001. Update: interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax. MMWR Morb. Mortal. Wkly. Rep. 50:10141016.
42. Chen, Y.,, J. Succi,, F. C. Tenover,, and T. M. Koehler. 2003. Beta-lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain. J. Bacteriol. 185:823830.
43. Chiang, S. R.,, and Y. C. Chuang. 2003. Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy. J. Microbiol. Immunol. Infect. 36:8188.
44. Choe, C. H.,, S. S. Bouhaouala,, I. Brook,, T. B. Elliot,, and G. B. Knudson. 2000. In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne. Antimicrob. Agents Chemother. 44:1766.
45. Chosewood, L. C.,, and D. E. Wilson (ed.). 2007. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. U.S. Government Printing Office, Washington, DC.
46. Chu, Y. W.,, T. K. Cheung,, V. Tung,, F. Tiu,, J. Lo,, R. Lam,, R. Lai,, and K. K. Wong. 2007. A blood isolate of Neisseria meningitidis showing reduced susceptibility to quinolones in Hong Kong. Int. J. Antimicrob. Agents 30:9495.
47. Chuang, Y. C.,, J. W. Liu,, W. C. Ko,, K. Y. Lin,, J. J. Wu,, and K. Y. Huang. 1997. In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob. Agents Chemother. 41:22142217.
48. Citron, D. M.,, and M. D. Appleman. 2006. In vitro activities of daptomycin, ciprofloxacin, and other antimicrobial agents against the cells and spores of clinical isolates of Bacillus species. J. Clin. Microbiol. 44:38143818.
49. Citron, D. M.,, Y. A. Warren,, H. T. Fernandez,, M. A. Goldstein,, K. L. Tyrrell,, and E. J. Goldstein. 2005. Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens. J. Clin. Microbiol. 43:24852488.
50.Clinical and Laboratory Standards Institute. 2010. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. Approved guideline M45-A2. CLSI, Wayne, PA.
51.Clinical and Laboratory Standards Institute. 2009. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 8th ed. Approved standard M07-A8. CLSI, Wayne, PA.
52.Clinical and Laboratory Standards Institute. 2009. Performance Standards for Antimicrobial Disk Susceptibility Tests, 10th ed. Approved standard M02-A10. CLSI, Wayne, PA.
53.Clinical and Laboratory Standards Institute. 2008. Performance Standards for Antimicrobial Susceptibility Testing. Eighteenth Informational Supplement. M100-S18. CLSI, Wayne, PA.
54.Clinical and Laboratory Standards Institute. 2010. Performance Standards for Antimicrobial Susceptibility Testing. Twentieth Informational Supplement. M100-S20. CLSI, Wayne, PA.
55. Corso, A.,, D. Faccone,, M. Miranda,, M. Rodriguez,, M. Regueira,, C. Carranza,, C. Vencina,, J. A. Vazquez,, and M. Galas. 2005. Emergence of Neisseria meningitidis with decreased susceptibility to ciprofloxacin in Argentina. J. Antimicrob. Chemother. 55:596597.
56. Critchley, I. A.,, S. D. Brown,, M. M. Traczewski,, G. S. Tillotson,, and N. Janjic. 2007. National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. faropenem surveillance study. Antimicrob. Agents Chemother. 51:43824389.
57. Dagan, R. 2009. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin. Microbiol. Infect. 15 (Suppl. 3):1620.
58. Dagan, R.,, and K. P. Klugman. 2008. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect. Dis. 8:785795.
59. Danielsen, M.,, P. J. Simpson,, E. B. O’Connor,, R. P. Ross,, and C. Stanton. 2007. Susceptibility of Pediococcus spp. To antimicrobial agents. J. Appl. Microbiol. 102:384389.
60. Das, S.,, R. Saha,, and I. R. Kaur. 2008. Trend of antibiotic resistance of Vibrio cholerae strains from East Delhi. Indian J. Med. Res. 127:478482.
61. Davis, J. A.,, and C. R. Jackson. 2009. Comparative antimicrobial susceptibility of Listeria monocytogenes, L. innocua, and L. welshimeri. Microb. Drug Resist. 15:2732.
62. Delgado, S.,, A. B. Florez,, and B. Mayo. 2005. Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract. Curr. Microbiol. 50:202207.
63. Deshpande, L. M.,, H. S. Sader,, T. R. Fritsche,, and R. N. Jones. 2006. Contemporary prevalence of BRO betalactamases in Moraxella catarrhalis: report from the SENTRY Antimicrobial Surveillance Program (North America, 1997 to 2004). J. Clin. Microbiol. 44:37753777.
64. Deye, G.,, J. Lewis,, J. Patterson,, and J. Jorgensen. 2003. A case of Leuconostoc ventriculitis with resistance to carbapenem antibiotics. Clin. Infect. Dis. 37:869870.
65. Dillon, J.-A. R.,, and K. H. Yeung. 1989. β-Lactamase plasmids and chromosomally mediated antibiotic resistance in pathogenic Neisseria species. Clin. Microbiol. Rev. 2(Suppl.):S125S133.
66. Doern, G. V.,, A. Brueggemann,, and G. Pierce. 1997. Assessment of the oxacillin disk screening test for determining penicillin resistance in Streptococcus pneumoniae. Eur. J. Clin. Microbiol. Infect. Dis. 16:311314.
67. Doern, G. V.,, K. P. Heilmann,, H. K. Huynh,, P. R. Rhomberg,, S. L. Coffman,, and A. B. Brueggemann. 2001. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob. Agents Chemother. 45:17211729.
68. Doern, G. V.,, and T. A. Tubert. 1987. Detection of blactamase activity among clinical isolates of Branhamella catarrhalis with six different b-lactamase assays. J. Clin. Microbiol. 25:13801383.
69. Doganay, M.,, and N. Aydin. 1991. Antimicrobial susceptibility of Bacillus anthracis. Scand. J. Infect. Dis. 23:333335.
70. Duck, W. M.,, J. Sobel,, J. M. Pruckler,, Q. Song,, D. Swerdlow,, C. Friedman,, A. Sulka,, B. Swaminathan,, T. Taylor,, M. Hoekstra,, P. Griffin,, D. Smoot,, R. Peek,, D. C. Metz,, P. B. Bloom,, S. Goldschmidt,, J. Parsonnet,, G. Triadafilopoulos,, G. I. Perez-Perez,, N. Vakil,, P. Ernst,, S. Czinn,, D. Dunne,, and B. D. Gold. 2004. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg. Infect. Dis. 10:10881094.
71. du Plessis, M.,, A. von Gottberg,, C. Cohen,, L. de Gouveia,, and K. P. Klugman. 2008. Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005. J. Clin. Microbiol. 46:32083214.
72. Engberg, J.,, F. M. Aarestrup,, D. E. Taylor,, P. Gerner-Smidt,, and I. Nachamkin. 2001. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7:2434.
73. Engler, K. H.,, M. Warner,, and R. C. George. 2001. In vitro activity of ketolides HMR 3004 and HMR 3647 and seven other antimicrobial agents against Corynebacterium diphtheriae. J. Antimicrob. Chemother. 47:2731.
74. Enriquez, R.,, R. Abad,, C. Salcedo,, S. Perez,, and J. A. Vazquez. 2008. Fluoroquinolone resistance in Neisseria meningitides in Spain. J. Antimicrob. Chemother. 61:286290.
75. Enriquez, R.,, R. Abad,, C. Salcedo,, and J. A. Vazquez. 2009. Nalidixic acid disk for laboratory detection of ciprofloxacin resistance in Neisseria meningitidis. Antimicrob. Agents Chemother. 53:796797.
76. Esel, D.,, Y. Ay-Altintop,, G. Yagmur,, S. Gokahmetoglu,, and B. Sumerkan. 2007. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis. Clin. Microbiol. Infect. 13:10231025.
77. Farrell, D. J.,, K. P. Klugman,, and M. Pichichero. 2007. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr. Infect. Dis. J. 26:123128.
78. Feder, H. M., Jr.,, J. C. Roberts,, J. C. Salazar,, H. B. Leopold,, and O. Toro-Salazar. 2003. HACEK endocarditis in infants and children: two cases and a literature review. Pediatr. Infect. Dis. J. 22:557562.
79. Felmingham, D. 2004. Comparative antimicrobial susceptibility of respiratory tract pathogens. Chemotherapy 50 (Suppl. 1):310.
80. Fernández-Natal, I.,, J. Guerra,, M. Alcoba,, F. Cachón,, and F. Soriano. 2001. Bacteremia caused by multiply resistant Corynebacterium urealyticum: six case reports and review. Eur. J. Clin. Microbiol. Infect. Dis. 20:514517.
81. Fernandez-Roblas, R.,, H. Adames,, N. Z. Martín-de-Hijas,, D. G. Almeida,, I. Gadea,, and J. Esteban. 2009. In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium. Int. J. Antimicrob. Agents 33:453455.
82. Fidalgo, S. G.,, C. J. Longbottom,, and T. V. Rjley. 2002. Susceptibility of Erysipelothrix rhusiopathiae to antimicrobial agents and home disinfectants. Pathology 34:462465.
83. Fontanals, D.,, V. Pineda,, I. Pons,, and J. C. Rojo. 1989. Penicillin-resistant beta-lactamase-producing Neisseria meningitides in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 8:9091.
84. Fritsche, T. R.,, H. S. Sader,, and R. N. Jones. 2007. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY Antimicrobial Surveillance Program (1999-2004). Diagn. Microbiol. Infect. Dis. 58:1926.
85. Funke, G.,, V. Punter,, and A. von Graevenitz. 1996. Antimicrobial susceptibility patterns of some recently established coryneform bacteria. Antimicrob. Agents Chemother. 40:28742878.
86. Galimand, M.,, A. Guiyoule,, G. Gerbaud,, B. Rasoamanana,, S. Chanteau,, E. Carniel,, and P. Courvalin. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337:677680.
87. Garcia-Cobos, S.,, J. Campos,, E. Cercenado,, F. Roman,, E. Lazaro,, M. Perez-Vazquez,, F. de Abajo,, and J. Oteo. 2008. Antibiotic resistance in Haemophilus influenzae decreased, except for beta-lactamase-negative amoxicillin-resistant isolates, in parallel with community antibiotic consumption in Spain from 1997 to 2007. Antimicrob. Agents Chemother. 52:27602766.
88. Gaudreau, C.,, Y. Girouard,, H. Gilbert,, J. Gagnon,, and S. Bekal. 2008. Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuni. Antimicrob. Agents Chemother. 52:44754477.
89. Gaudreau, C.,, Y. Girouard,, L. Ringuette,, and C. Tsimiklis. 2007. Comparison of disk diffusion and agar dilution methods for erythromycin and ciprofloxacin susceptibility testing of Campylobacter jejuni subsp. jejuni . Antimicrob. Agents Chemother. 51:15241526.
90. Gephart, J. F.,, and J. A. Washington II. 1982. Antimicrobial susceptibilities of nutritionally variant streptococci. J. Infect. Dis. 146:536539.
91. Gerrits, M. M.,, A. H. van Vliet,, E. J. Kuipers,, and J. G. Kusters. 2006. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect. Dis. 6:699709.
92. Glikman, D.,, S. M. Matushek,, M. D. Kahana,, and R. S. Daum. 2006. Pneumonia and empyema caused by penicillinresistant Neisseria meningitidis: a case report and literature review. Pediatrics 117:e1061e1066.
93. Glupczynski, Y.,, N. Broutet,, A. Cantagrel,, L. P. Andersen,, T. Alarcon,, M. Lopez-Brea,, and F. Megraud. 2002. Comparison of the Etest and agar dilution method for antimicrobial susceptibility testing of Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 21:549552.
94. Godreuil, S.,, M. Galimand,, G. Gerbaud,, C. Jacquet,, and P. Courvalin. 2003. Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes. Antimicrob. Agents Chemother. 47:704708.
95. Goldstein, E. J.,, D. M. Citron,, C. V. Merriam,, Y. A. Warren,, K. L. Tyrrell,, and H. Fernandez. 2002. In vitro activities of a new des-fluoroquinolone, BMS 284756, and seven other antimicrobial agents against 151 isolates of Eikenella corrodens. Antimicrob. Agents Chemother. 46:11411143.
96. Goldstein, E. J.,, D. M. Citron,, C. V. Merriam,, Y. A. Warren,, K. L. Tyrrell,, and H. T. Fernandez. 2002. In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species. Antimicrob. Agents Chemother. 46:30683070.
97. Gomez-Garces, J. L.,, J. I. Alos,, and J. Tamayo. 2007. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria. Int. J. Antimicrob. Agents 29:688692.
98. Gonzalez-Rey, C.,, S. B. Svenson,, L. Bravo,, A. Siitonen,, V. Pasquale,, S. Dumontet,, I. Ciznar,, and K. Krovacek. 2004. Serotypes and anti-microbial susceptibility of Plesiomonas shigelloides isolates from humans, animals and aquatic environments in different countries. Comp. Immunol. Microbiol. Infect. Dis. 27:129139.
99. Gorby, G. L.,, and J. E. Peacock, Jr. 1988. Erysipelothrix rhusiopathiae endocarditis: microbiologic, epidemiologic, and clinical features of an occupational disease. Rev. Infect. Dis. 10:317325.
100. Gracia, M.,, C. Diaz,, P. Coronel,, M. Gimeno,, R. Garcia- Rodas,, G. del Prado,, L. Huelves,, V. Ruiz,, P. L. Naves,, M. C. Ponte,, J. J. Granizo,, and F. Soriano. 2008. Antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis isolates in eight Central, East and Baltic European countries in 2005-06: results of the Cefditoren Surveillance Study. J. Antimicrob Chemother. 61:11801181.
101. Grandiere-Perez, L.,, C. Jacqueline,, V. Lemabecque,, O. Patey,, G. Potel,, and J. Caillon. 2005. Eagle effect in Corynebacterium diphtheriae. J. Infect. Dis. 191:21182120.
102. Green, M. D.,, B. Beall,, M. J. Marcon,, C. H. Allen,, J. S. Bradley,, B. Dashefsky,, J. R. Gilsdorf,, G. E. Schutze,, C. Smith,, E. B. Walter,, J. M. Martin,, K. M. Edwards,, K. A. Barbadora,, and E. R. Wald. 2006. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. J. Antimicrob. Chemother. 57:12401243.
103. Grignon, B.,, J. Tankovic,, F. Megraud,, Y. Glupczynski,, M. O. Husson,, M. C. Conroy,, J. P. Emond,, J. Loulergue,, J. Raymond,, and J. L. Fauchere. 2002. Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. Microb. Drug Resist. 8:6166.
104. Guiyoule, A.,, G. Gerbaud,, C. Buchrieser,, M. Galimand,, L. Rahalison,, S. Chanteau,, P. Courvalin,, and E. Carniel. 2001. Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg. Infect. Dis. 7:4348.
105. Guthrie, L.,, S. Banks,, W. Setiawan,, and K. B. Waites. 1999. Comparison of MicroScan MICroSTREP, PASCO, and Sensititre MIC panels for determining antimicrobial susceptibilities of Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 33:267273.
106. Hansen, J. M.,, P. Gerner-Smidt,, and B. Bruun. 2005. Antibiotic susceptibility of Listeria monocytogenes in Denmark 1958-2001. APMIS 113:3136.
107. Hansman, D.,, S. Wati,, A. Lawrence,, and J. Turnidge. 2004. Have South Australian isolates of Neisseria meningitides become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999. Pathology 36:160165.
108. Hasegawa, K.,, R. Kobayashi,, E. Takada,, A. Ono,, N. Chiba,, M. Morozumi,, S. Iwata,, K. Sunakawa,, and K. Ubukata. 2006. High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. J. Antimicrob. Chemother. 57:10771082.
109. Heelan, J. S.,, D. Chesney,, and G. Guadagno. 1992. Investigation of ampicillin-intermediate strains of Haemophilus influenzae by using the disk diffusion procedure and current National Committee for Clinical Laboratory Standards guidelines. J. Clin. Microbiol. 30:16741677.
110. Heilmann, K. P.,, C. L. Rice,, A. L. Miller,, N. J. Miller,, S. E. Beekmann,, M. A. Pfaller,, S. S. Richter,, and G. V. Doern. 2005. Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrob. Agents Chemother. 49:25612564.
111. Hirakata, Y.,, J. Matsuda,, M. Nakano,, T. Hayashi,, S. Tozaka,, T. Takezawa,, H. Takahashi,, Y. Higashiyama,, Y. Miyazaki,, S. Kamihira,, and S. Kohno. 2005. Evaluation of the BD Phoenix Automated Microbiology System SMIC/ID panel for identification and antimicrobial susceptibility testing of Streptococcus spp. Diagn. Microbiol. Infect. Dis. 53:169173.
112. Ho, P. L.,, R. W. Yung,, D. N. Tsang,, T. L. Que,, M. Ho,, W. H. Seto,, T. K. Ng,, W. C. Yam,, and W. W. Ng. 2001. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J. Antimicrob. Chemother. 48:659665.
113. Hoban, D.,, and D. Felmingham. 2002. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J. Antimicrob. Chemother. 50 (Suppl. S1):4959.
114. Horodniceanu, T.,, A. Buu-Hoi,, A. Delbos,, and G. Bieth. 1982. High-level aminoglycoside resistance in Group A, B, C, D (Streptococcus bovis), and viridans streptococci. Antimicrob. Agents Chemother. 21:176179.
115. Igbinosa, E. O.,, and A. I. Okoh. 2008. Emerging Vibrio species: an unending threat to public health in developing countries. Res. Microbiol. 159:495506.
116. Ikaheimo, I.,, H. Syrjala,, J. Karhukorpi,, R. Schildt,, and M. Koskela. 2000. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals. J. Antimicrob. Chemother. 46:287290.
117. Inglis, T. J. J.,, F. Rodrigues,, P. Rigby,, R. Norton,, and B. J. Currie. 2004. Comparison of the susceptibilities of Burkholderia pseudomallei to meropenem and ceftazidime by conventional and intracellular methods. Antimicrob. Agents Chemother. 48:29993005.
118. Inoue, M.,, D. J. Farrell,, K. Kaneko,, K. Akizawa,, S. Fujita,, M. Kaku,, J. Igari,, K. Yamaguchi,, K. Yamanaka,, M. Murase,, S. Asari,, Y. Hirakata,, H. Baba,, and H. Itaha. 2008. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004). Microb. Drug Resist. 14:109117.
119. Jacobs, E.,, A. Dalhoff,, and G. Korfmann. 2009. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study). Int. J. Antimicrob. Agents 33:5257.
120. Jansen, W. T.,, A. Verel,, M. Beitsma,, J. Verhoef,, and D. Milatovic. 2008. Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada. Curr. Med. Res. Opin. 24:28532861.
121. Johnson, D. M.,, H. S. Sader,, T. R. Fritsche,, D. J. Biedenbach,, and R. N. Jones. 2003. Susceptibility trends of Haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program. Diagn. Microbiol. Infect. Dis. 47:373376.
122. Jones, R.,, D. Johnson,, M. Erwin,, M. Beach,, D. Biedenbach,, and M. Pfaller. 1999. Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and Etest method validation. Diagn. Microbiol. Infect. Dis. 34:9198.
123. Jones, R. N.,, S. Kohno,, Y. Ono,, J. E. Ross,, and K. Yanagihara. 2009. ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries. Diagn. Microbiol. Infect. Dis. 64:191201.
124. Jones, R. N.,, J. E. Ross,, M. Castanheira,, and R. E. Mendes. 2008. United States resistance surveillance results for linezolid (LEADER Program for 2007). Diagn. Microbiol. Infect. Dis. 62:416426.
125. Jones, R. N.,, H. S. Sader,, T. R. Fritsche,, and S. Pottumarthy. 2007. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn. Microbiol. Infect. Dis. 57:109116.
126. Jones, R. N.,, M. G. Stilwell,, P. A. Hogan,, and D. J. Sheehan. 2007. Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 51:14911493.
127. Jorgensen, J.,, M. McElmeel,, and S. Crawford. 1998. Evaluation of the Dade MicroScan MICroSTREP antimicrobial susceptibility testing panel with selected Streptococcus pneumoniae challenge strains and recent clinical isolates. J. Clin. Microbiol. 36:788791.
128. Jorgensen, J. H.,, A. L. Barry,, M. M. Traczewski,, D. F. Sahm,, M. L. McElmeel,, and S. A. Crawford. 2000. Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux Vitek 2. J. Clin. Microbiol. 38:28142818.
129. Jorgensen, J. H.,, S. A. Crawford,, and K. R. Fiebelkorn. 2005. Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents. J. Clin. Microbiol. 43:31623171.
130. Jorgensen, J. H.,, M. J. Ferraro,, M. L. McElmeel,, J. Spargo,, J. M. Swenson,, and F. C. Tenover. 1994. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the Etest. J. Clin. Microbiol. 32:159163.
131. Jorgensen, J. H.,, A. W. Howell,, and L. A. Maher. 1991. Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the Etest. J. Clin. Microbiol. 29:109114.
132. Kadry, A. A.,, S. I. Fouda,, N. A. Elkhizzi,, and A. M. Shibl. 2003. Correlation between susceptibility and BRO type enzyme of Moraxella catarrhalis strains. Int. J. Antimicrob. Agents 22:532536.
133. Kain, K. C.,, and M. T. Kelly. 1989. Antimicrobial susceptibility of Plesiomonas shigelloides from patients with diarrhea. Antimicrob. Agents Chemother. 33:16091610.
134. Kim, D. M.,, Y. Lym,, S. J. Jang,, H. Han,, Y. G. Kim,, C. H. Chung,, and S. P. Hong. 2005. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus. Antimicrob. Agents Chemother. 49:34893491.
135. Kim, J. J.,, J. G. Kim,, and D. H. Kwon. 2003. Mixedinfection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter 8:202206.
136. Kimura, K.,, S. Suzuki,, J. Wachino,, H. Kurokawa,, K. Yamane,, N. Shibata,, N. Nagano,, H. Kato,, K. Shibayama,, and Y. Arakawa. 2008. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 52:28902897.
137. Kinsara, A.,, A. Al-Mowallad,, and A. O. Osoba. 1999. Increasing resistance of brucellae to co-trimoxazole. Antimicrob. Agents Chemother. 43:1531.
138. Kiyomizu, K.,, T. Yagi,, H. Yoshida,, R. Minami,, A. Tanimura,, T. Karasuno,, and A. Hiraoka. 2008. Fulminant septicemia of Bacillus cereus resistant to carbapenem in a patient with biphenotypic acute leukemia. J. Infect. Chemother. 14:361367.
139. Klare, I.,, C. Konstabel,, G. Werner,, G. Huys,, V. Vankerckhoven,, G. Kahlmeter,, B. Hildebrandt,, S. Muller-Bertling,, W. Witte,, and H. Goossens. 2007. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J. Antimicrob. Chemother. 59:900912.
140. Klugman, K. P.,, D. E. Low,, J. Metlay,, J.-C. Pechere,, and K. Weiss. 2004. Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilities. Int. J. Antimicrob. Agents 24:411422.
141. Ko, W.,, K. Yu,, C. Liu,, C. Huang,, H. Leu,, and Y. Chuang. 1996. Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan. Antimicrob. Agents Chemother. 40:12601262.
142. Ko, W.-C.,, H.-M. Wu,, T.-C. Chang,, J.-J. Yan,, and J.-J. Wu. 1998. Inducible beta-lactam resistance in Aeromonas hydrophila: therapeutic challenge for antimicrobial therapy. J. Clin. Microbiol. 36:31883192.
143. Kobayashi, I.,, K. Murakami,, M. Kato,, S. Kato,, T. Azuma,, S. Takahashi,, N. Uemura,, T. Katsuyama,, Y. Fukuda,, K. Haruma,, M. Nasu,, and T. Fujioka. 2007. Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005. J. Clin. Microbiol. 45:40064010.
144. Krcmery, V., Jr.,, S. Spanik,, and J. Trupl. 1996. First report of vancomycin-resistant Streptococcus mitis bacteremia in a leukemic patient after prophylaxis with quinolones and during treatment with vancomycin. J. Chemother. 8:325326.
145. Kugler, K. C.,, D. J. Biedenbach,, and R. N. Jones. 1999. Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms. Diagn. Microbiol. Infect. Dis. 34:7376.
146. Kulik, E. M.,, K. Lenkeit,, S. Chenaux,, and J. Meyer. 2008. Antimicrobial susceptibility of periodontopathogenic bacteria. J. Antimicrob. Chemother. 61:10871091.
147. Kupronis, B. A.,, C. L. Richards,, and C. G. Whitney. 2003. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community. J. Am. Geriatr. Soc. 51:15201525.
148. Kyaw, M. H.,, R. Lynfield,, W. Schaffner,, A. S. Craig,, J. Hadler,, A. Reingold,, A. R. Thomas,, L. H. Harrison,, N. M. Bennett,, M. M. Farley,, R. R. Facklam,, J. H. Jorgensen,, J. Besser,, E. R. Zell,, A. Schuchat,, and C. G. Whitney. 2006. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354:14551463.
149. Lagrou, K.,, J. Verhaegen,, M. Janssens,, G. Wauters,, and L. Verbist. 1998. Prospective study of catalase-positive coryneform organisms in clinical specimens: identification, clinical relevance, and antibiotic susceptibility. Diagn. Microbiol. Infect. Dis. 30:715.
150. Lamy, B.,, A. Kodjo,, and F. Laurent. 2009. Prospective nationwide study of Aeromonas infections in France. J. Clin. Microbiol. 47:12341237.
151. LeQuellec, A.,, D. Bessis,, C. Perez,, and A. J. Ciurana. 1994. Endocarditis due to beta-lactamase-producing Cardiobacterium hominis. Clin. Infect. Dis. 19:994995.
152. Levin, J. M.,, and D. A. Talan. 1990. Erythromycin failure with subsequent Pasteurella multocida meningitis and septic arthritis in a cat-bite victim. Ann. Emerg. Med. 19:14581461.
153. Liao, C. H.,, L. J. Teng,, P. R. Hsueh,, Y. C. Chen,, L. M. Huang,, S. C. Chang,, and S. W. Ho. 2004. Nutritionally variant streptococcal infections at a University Hospital in Taiwan: disease emergence and high prevalence of beta-lactam and macrolide resistance. Clin. Infect. Dis. 38:452455.
154. Libisch, B.,, C. G. Giske,, B. Kovacs,, T. G. Toth,, and M. Fuzi. 2008. Identification of the first VIM metallo-betalactamase-producing multiresistant Aeromonas hydrophila strain. J. Clin. Microbiol. 46:18781880.
155. Lightfoot, N. F.,, R. J. D. Scott,, and P. C. B. Turnbull. 1990. Antimicrobial susceptibility of Bacillus anthracis. Salisbury Med. Bull. 68 (Suppl. ):9598.
156. Lion, C.,, M. C. Conroy,, A. M. Carpentier,, and A. Lozniewski. 2006. Antimicrobial susceptibilities of Pasteurella strains isolated from humans. Int. J. Antimicrob. Agents 27:290293.
157. Lion, C.,, A. Lozniewski,, V. Rosner,, and M. Weber. 1999. Lung abscess due to beta-lactamase-producing Pasteurella multocida. Clin. Infect. Dis. 29:13451346.
158. Lonks, J. R.,, J. Garau,, L. Gomez,, M. Xercavins,, A. Ochoa de Echaguen,, I. F. Gareen,, P. T. Reiss,, and A. A. Medeiros. 2002. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 35:556564.
159. Low, D. E. 2005. Changing trends in antimicrobial-resistant pneumococci: it’s not all bad news. Clin. Infect. Dis. 41(Suppl. 4):S228S233.
160. Lu, P. L.,, P. R. Hsueh,, C. C. Hung,, L. J. Teng,, T. N. Jang,, and K. T. Luh. 2000. Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis. J. Clin. Microbiol. 38:20152017.
161. Madinier, I. M.,, T. B. Fosse,, C. Hitzig,, Y. Charbit,, and L. R. Hannoun. 1999. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomycetemcomitans. J. Periodontol. 70:888892.
162. Maluping, R. P.,, C. R. Lavilla-Pitogo,, A. DePaola,, J. M. Janda,, K. Krovacek,, and C. Greko. 2005. Antimicrobial susceptibility of Aeromonas spp., Vibrio spp. and Plesiomonas shigelloides isolated in the Philippines and Thailand. Int. J. Antimicrob. Agents 25:348350.
163. Manchanda, V.,, and P. Bhalla. 2006. Emergence of nonceftriaxone- susceptible Neisseria meningitidis in India. J. Clin. Microbiol. 44:42904291.
164. Marco, F.,, M. Almela,, J. Nolla-Salas,, P. Coll,, I. Gasser,, M. D. Ferrer,, and M. de Simon. 2000. In vitro activities of 22 antimicrobial agents against Listeria monocytogenes strains isolated in Barcelona, Spain. Diagn. Microbiol. Infect. Dis. 38:259261.
165. Marshall, S. A.,, P. R. Rhomberg,, and R. N. Jones. 1997. Comparative evaluation of Etest for susceptibility testing Neisseria meningitidis with eight antimicrobial agents. An investigation using U.S. Food and Drug Administration regulatory criteria. Diagn. Microbiol. Infect. Dis. 27:9397.
166. Martinez-Martinez, L.,, P. Joyanes,, A. I. Suarez,, and E. J. Perea. 2001. Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples. Antimicrob. Agents Chemother. 45:23902392.
167. Megraud, F. 2007. Helicobacter pylori and antibiotic resistance. Gut 56:1502.
168. Megraud, F.,, N. Lehn,, T. Lind,, E. Bayerdorffer,, C. O’Morain,, R. Spiller,, P. Unge,, S. V. van Zanten,, M. Wrangstadh,, and C. F. Burman. 1999. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob. Agents Chemother. 43:27472752.
169. Megraud, F.,, and P. Lehours. 2007. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin. Microbiol. Rev. 20:280322.
170. Mehta, G.,, and R. Goyal. 2007. Emerging fluoroquinolone resistance in Neisseria meningitidis in India: cause for concern. J. Antimicrob. Chemother. 59:329330.
171. Memish, Z.,, M. W. Mah,, S. Al Mahmoud,, M. Al Shaalan,, and M. Y. Khan. 2000. Brucella bacteraemia: clinical and laboratory observations in 160 patients. J. Infect. 40:5963.
172. Mendelman, P. M.,, E. A. Wiley,, T. L. Stull,, C. Clausen,, D. O. Chaffin,, and O. Onay. 1990. Problems with current recommendations for susceptibility testing of Haemophilus influenzae. Antimicrob. Agents Chemother. 34:14801484.
173. Moet, G. J.,, M. J. Dowzicky,, and R. N. Jones. 2007. Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci. Diagn. Microbiol. Infect. Dis. 57:333336.
174. Mohammed, M. J.,, C. K. Marston,, T. Popovic,, R. S. Weyant,, and F. C. Tenover. 2002. Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J. Clin. Microbiol. 40:19021907.
175. Morrissey, I.,, K. Maher,, L. Williams,, J. Shackcloth,, D. Felmingham,, and R. Reynolds. 2008. Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007. J. Antimicrob. Chemother. 62(Suppl. 2):ii97ii103.
176. Mortensen, J. E.,, M. J. Gerrety,, and L. D. Gray. 2006. Surveillance of antimicrobial resistance in Neisseria meningitides from patients in the Cincinnati tristate region (Ohio, Kentucky, and Indiana). J. Clin. Microbiol. 44:15921593.
177. Mortensen, J. E.,, O. Giger,, and G. L. Rodgers. 1998. In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida. Diagn. Microbiol. Infect. Dis. 30:99102.
178. Murray, C. K.,, E. A. Walter,, S. Crawford,, M. L. McElmeel,, and J. H. Jorgensen. 2001. Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates. Clin. Infect. Dis. 32:E140E142.
179. Musher, D. M.,, J. G. Bartlett,, and G. V. Doern. 2001. A fresh look at the definition of susceptibility of Streptococcus pneumoniae to {beta}-lactam antibiotics. Arch. Intern. Med. 161:25382544.
180. Namdari, H.,, K. Kintner,, B. A. Jackson,, S. Namdari,, J. L. Hughes,, R. R. Peairs,, and D. J. Savage. 1999. Abiotrophia species as a cause of endophthalmitis following cataract extraction. J. Clin. Microbiol. 37:15641566.
181. Nariai, A. 2007. Prevalence of beta-lactamase-nonproducing ampicillin-resistant Haemophilus influenzae and Haemophilus influenzae type b strains obtained from children with lower respiratory tract infections. J. Infect. Chemother. 13:396399.
182. Niki, Y.,, H. Hanaki,, T. Matsumoto,, M. Yagisawa,, S. Kohno,, N. Aoki,, A. Watanabe,, J. Sato,, R. Hattori,, M. Terada,, N. Koashi,, T. Kozuki,, A. Maruo,, K. Morita,, K. Ogasawara,, Y. Takahashi,, J. Watanabe,, K. Takeuchi,, S. Fujimura,, H. Takeda,, H. Ikeda,, N. Sato,, K. Niitsuma,, M. Saito,, S. Koshiba,, M. Kaneko,, M. Miki,, S. Nakanowatari,, Y. Honda,, J. Chiba,, H. Takahashi,, M. Utagawa,, T. Kondo,, A. Kawana,, H. Konosaki,, Y. Aoki,, H. Ueda,, H. Sugiura,, M. Ichioka,, H. Goto,, D. Kurai,, M. Okazaki,, K. Yoshida,, T. Yoshida,, Y. Tanabe,, S. Kobayashi,, M. Okada,, H. Tsukada,, Y. Imai,, Y. Honma,, K. Nishikawa,, T. Yamamoto,, A. Kawai,, T. Kashiwabara,, Y. Takesue,, Y. Wada,, K. Nakajima,, T. Miyara,, H. Toda,, N. Mitsuno,, H. Sugimura,, S. Yoshioka,, M. Kurokawa,, Y. Munekawa,, H. Nakajima,, S. Kubo,, Y. Ohta,, K. Mikasa,, K. Maeda,, K. Kasahara,, A. Koizumi,, R. Sano,, S. Yagi,, M. Takaya,, Y. Kurokawa,, N. Kusano,, E. Mihara,, M. Kuwabara,, Y. Fujiue,, T. Ishimaru,, N. Matsubara,, Y. Kawasaki,, H. Tokuyasu,, K. Masui,, K. Negayama,, N. Ueda,, M. Ishimaru,, Y. Nakanishi,, M. Fujita,, J. Honda,, J. Kadota,, K. Hiramatsu,, Z. Nagasawa,, M. Suga,, H. Muranaka,, K. Yanagihara,, J. Fujita,, M. Tateyama,, K. Sunakawa,, and K. Totsuka. 2009. Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens’ antibacterial susceptibility. J. Infect. Chemother. 15:156167.
183. Norskov-Lauritsen, N.,, H. Marchandin,, and M. J. Dowzicky. 2009. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007). Int. J. Antimicrob. Agents 34:121130.
184. Okeke, I. N.,, O. A. Aboderin,, D. K. Byarugaba,, K. K. Ojo,, and J. A. Opintan. 2007. Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg. Infect. Dis. 13:16401646.
185. Osaka, K.,, T. Takakura,, K. Narukawa,, M. Takahata,, K. Endo,, H. Kiyota,, and S. Onodera. 2008. Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone. J. Infect. Chemother. 14:195203.
186. Osato, M. S.,, R. Reddy,, S. G. Reddy,, R. L. Penland,, and D. Y. Graham. 2001. Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori. Int. J. Antimicrob. Agents 17:3944.
187. Osato, M. S.,, R. Reddy,, S. G. Reddy,, R. L. Penland,, H. M. Malaty,, and D. Y. Graham. 2001. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch. Intern. Med. 161:12171220.
188. Otsuka, Y.,, Y. Kawamura,, T. Koyama,, H. Iihara,, K. Ohkusu,, and T. Ezaki. 2005. Corynebacterium resistens sp. nov., a new multidrug-resistant coryneform bacterium isolated from human infections. J. Clin. Microbiol. 43:37133717.
189. Ottaviani, D.,, I. Bacchiocchi,, L. Masini,, F. Leoni,, A. Carraturo,, M. Giammarioli,, and G. Sbaraglia. 2001. Antimicrobial susceptibility of potentially pathogenic halophilic vibrios isolated from seafood. Int. J. Antimicrob. Agents 18:135140.
190. Owen, R. J. 2002. Molecular testing for antibiotic resistance in Helicobacter pylori. Gut 50:285289.
191. Ozawa, M.,, K. Yamamoto,, A. Kojima,, M. Takagi,, and T. Takahashi. 2009. Etiological and biological characteristics of Erysipelothrix rhusiopathiae isolated between 1994 and 2001 from pigs with swine erysipelas in Japan. J. Vet. Med. Sci. 71:697702.
192. Pascual, A.,, P. Joyanes,, L. Martinez-Martinez,, A. I. Suarez,, and E. J. Perea. 1996. Comparison of broth microdilution and E-test for susceptibility testing of Neisseria meningitidis. J. Clin. Microbiol. 34:588591.
193. Paturel, L.,, J. P. Casalta,, G. Habib,, M. Nezri,, and D. Raoult. 2004. Actinobacillus actinomycetemcomitans endocarditis. Clin. Microbiol. Infect. 10:98118.
194. Pereira, G. A.,, F. P. Pimenta,, F. R. Santos,, P. V. Damasco,, R. Hirata Júnior,, and A. L. Mattos-Guaraldi. 2008. Antimicrobial resistance among Brazilian Corynebacterium diphtheriae strains. Mem. Inst. Oswaldo Cruz 103:507510.
195. Perez-Trallero, E.,, N. Gomez,, and J. M. Garcia-Arenzana. 1994. Etest as susceptibility test for evaluation of Neisseria meningitidis isolates. J. Clin. Microbiol. 32:23412342.
196. Phares, C. R.,, R. Lynfield,, M. M. Farley,, J. Mohle- Boetani,, L. H. Harrison,, S. Petit,, A. S. Craig,, W. Schaffner,, S. M. Zansky,, K. Gershman,, K. R. Stefonek,, B. A. Albanese,, E. R. Zell,, A. Schuchat,, and S. J. Schrag. 2008. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299:20562065.
197. Philippon, A.,, and F. Bimet. 1990. In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 9:892895.
198. Piccolomini, R.,, G. Di Bonaventura,, G. Catamo,, F. Carbone,, and M. Neri. 1997. Comparative evaluation of the Etest, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J. Clin. Microbiol. 35:18421846.
199. Piper, K. E.,, J. M. Steckelberg,, and R. Patel. 2005. In vitro activity of daptomycin against clinical isolates of Grampositive bacteria. J. Infect. Chemother. 11:207209.
200. Pletz, M. W.,, L. McGee,, J. Jorgensen,, B. Beall,, R. R. Facklam,, C. G. Whitney,, and K. P. Klugman. 2004. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob. Agents Chemother. 48:34913497.
201. Pottumarthy, S.,, T. R. Fritsche,, and R. N. Jones. 2005. Comparative activity of oral and parenteral cephalosporins tested against multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1997-2003). Diagn. Microbiol. Infect. Dis. 51:147150.
202. Poyart, C.,, C. Pierre,, G. Quesne,, B. Pron,, P. Berche,, and P. Trieu-Cuot. 1997. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a VAN-B transferable determinant in Streptococcus bovis. Antimicrob. Agents Chemother. 41:2429.
203. Poyart, C.,, G. Quesne,, P. Acar,, P. Berche,, and P. Trieu-Cuot. 2000. Characterization of the Tn916-like transposon Tn3872 in a strain of Abiotrophia defectiva (Streptococcus defectivus) causing sequential episodes of endocarditis in a child. Antimicrob. Agents Chemother. 44:790793.
204. Price, L. B.,, A. Vogler,, T. Pearson,, J. D. Busch,, J. M. Schupp,, and P. Keim. 2003. In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin. Antimicrob. Agents Chemother. 47:23622365.
205. Rainbow, J.,, E. Cebelinski,, J. Bartkus,, A. Glennen,, D. Boxrud,, and R. Lynfield. 2005. Rifampin-resistant meningococcal disease. Emerg. Infect. Dis. 11:977979.
206. Reinert, R. R. 2009. The antimicrobial resistance profile of Streptococcus pneumoniae. Clin. Microbiol. Infect. 15 (Suppl. 3):711.
207. Richter, S. S.,, K. A. Gordon,, P. R. Rhomberg,, M. A. Pfaller,, and R. N. Jones. 2001. Neisseria meningitidis with decreased susceptibility to penicillin: report from the SENTRY Antimicrobial Surveillance Program, North America, 1998-99. Diagn. Microbiol. Infect. Dis. 41:8388.
208. Richter, S. S.,, K. P. Heilmann,, C. L. Dohrn,, F. Riahi,, S. E. Beekmann,, and G. V. Doern. 2009. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Clin. Infect. Dis. 48:e2333.
209. Richter, S. S.,, W. J. Howard,, M. P. Weinstein,, D. A. Bruckner,, J. F. Hindler,, M. Saubolle,, and G. V. Doern. 2007. Multicenter evaluation of the BD Phoenix automated microbiology system for antimicrobial susceptibility testing of Streptococcus species. J. Clin. Microbiol. 45:28632871.
210. Richter, S. S.,, P. L. Winokur,, A. B. Brueggemann,, H. K. Huynh,, P. R. Rhomberg,, E. M. Wingert,, and G. V. Doern. 2000. Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella catarrhalis) obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998. Antimicrob. Agents Chemother. 44:444446.
211. Riegel, P.,, R. Ruimy,, R. Christen,, and H. Monteil. 1996. Species identities and antimicrobial susceptibilities of corynebacteria isolated from various clinical sources. Eur. J. Clin. Microbiol. Infect. Dis. 15:657662.
212. Rodriguez, C. N.,, A. J. Rodriguez-Morales,, A. Garcia,, B. Pastran,, A. Rios,, A. Calvo,, I. Jimenez,, and P. Meijomil. 2005. Quinolone and azithromycin-resistant Neisseria meningitides serogroup C causing urethritis in a heterosexual man.